• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FCS Advancing Therapies for Patients Through Clinical Research in Community Oncology Practices

Article

Florida Cancer Specialists & Research Institute provides the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.

The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly 3 decades, thanks in large part to scientific discoveries and treatment advances. Florida Cancer Specialists & Research Institute (FCS) physicians and patients are part of these leading-edge cancer innovations, providing the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.

This is possible through FCS' long-standing partnership with Sarah Cannon—a trusted expert in the field of oncology research having conducted more than 500 first-in-human trials and been a clinical trial leader in the majority of approved cancer therapies over the last decade.

Since the inception of our research program, 10,000 patients have participated in innovative studies.

Learn more.

Related Videos
 Rakendu Rajendran, MBBS, Virtua Health
Dr Brian Mulherin
Dr Brian Mulherin
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Vivek Bhalla, MD, Stanford University School of Medicine
Dr Brian Mulherin
Emma Guttman, MD, PhD, Icahn School of Medicine at Mount Sinai
Dr Davey Daniel
Dr Davey Daniel
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.